ProPhase Inventory from 2010 to 2026

PRPH Stock  USD 0.16  0.01  5.88%   
ProPhase Labs' Inventory is decreasing with very volatile movements from year to year. Inventory is predicted to flatten to about 977.3 K. For the period between 2010 and 2026, ProPhase Labs, Inventory quarterly trend regression had mean deviation of  1,001,905 and range of 4.5 M. View All Fundamentals
 
Inventory  
First Reported
1996-12-31
Previous Quarter
830 K
Current Value
266 K
Quarterly Volatility
2.5 M
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check ProPhase Labs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ProPhase Labs' main balance sheet or income statement drivers, such as Interest Expense of 4 M, Selling General Administrative of 32.4 M or Total Revenue of 7.4 M, as well as many indicators such as Price To Sales Ratio of 2.33, Dividend Yield of 0.13 or PTB Ratio of 2.15. ProPhase financial statements analysis is a perfect complement when working with ProPhase Labs Valuation or Volatility modules.
  
Build AI portfolio with ProPhase Stock
Check out the analysis of ProPhase Labs Correlation against competitors.
For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.
The Inventory trend for ProPhase Labs offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether ProPhase Labs is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest ProPhase Labs' Inventory Growth Pattern

Below is the plot of the Inventory of ProPhase Labs over the last few years. It is ProPhase Labs' Inventory historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ProPhase Labs' overall financial position and show how it may be relating to other accounts over time.
Inventory10 Years Trend
Very volatile
   Inventory   
       Timeline  

ProPhase Inventory Regression Statistics

Arithmetic Mean2,333,351
Geometric Mean1,846,493
Coefficient Of Variation53.77
Mean Deviation1,001,905
Median2,291,000
Standard Deviation1,254,679
Sample Variance1.6T
Range4.5M
R-Value(0.07)
Mean Square Error1.7T
R-Squared0
Significance0.79
Slope(17,446)
Total Sum of Squares25.2T

ProPhase Inventory History

2026977.3 K
2025M
20241.1 M
20232.3 M
2022M
20214.6 M
2020M

Other Fundumenentals of ProPhase Labs

ProPhase Labs Inventory component correlations

About ProPhase Labs Financial Statements

Investors use fundamental indicators, such as ProPhase Labs' Inventory, to determine how well the company is positioned to perform in the future. Although ProPhase Labs' investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
InventoryM977.3 K
Change To Inventory1.6 M1.6 M
Inventory Turnover 5.45  3.67 
Days Of Inventory On Hand 69.33  131.75 
Average Inventory4.5 M5.7 M
Days Of Inventory Outstanding 69.33  131.75 

Currently Active Assets on Macroaxis

When determining whether ProPhase Labs offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ProPhase Labs' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Prophase Labs Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Prophase Labs Stock:
Check out the analysis of ProPhase Labs Correlation against competitors.
For more detail on how to invest in ProPhase Stock please use our How to Invest in ProPhase Labs guide.
You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Is there potential for Pharmaceuticals market expansion? Will ProPhase introduce new products? Factors like these will boost the valuation of ProPhase Labs. Anticipated expansion of ProPhase directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.95)
Earnings Share
(18.05)
Revenue Per Share
1.402
Quarterly Revenue Growth
(0.38)
Return On Assets
(0.23)
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between ProPhase Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProPhase Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, ProPhase Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.